Table 1 Baseline clinical characteristics of the 92 enrolled patients
|  | CCRT (n = 25) | Chemotherapy (n = 67) |
|---|---|---|
Median age at diagnosis, years (range) | 56 (32 – 75) | 58 (26 – 78) |
Sex, n (%) | Â | Â |
 Male | 19 (76.0) | 53 (79.1) |
 Female | 6 (24.0) | 14 (20.9) |
ECOG, n (%) | Â | Â |
 0 | 10 (40.0) | 39 (58.2) |
 1 | 14 (56.0) | 24 (35.8) |
 2 | 1 (4.0) | 4 (6.0) |
Tumor stage, n (%) | Â | Â |
 Stage IVa | 14 (56.0) | 29 (43.3) |
 Stage IVb | 11 (44.0) | 38 (56.7) |
Tumor characteristics | Â | Â |
 Maximum diameter, cm | 7.6 ± 3.9 | 7.4 ± 3.1 |
 Location of intrahepatic lesions, n (%) |  |  |
  Unifocal | 18 (72.0) | 27 (40.7) |
  Multifocal | 7 (28.0) | 40 (59.7) |
 Radiographic gross type, n (%) |  |  |
  Mass-forming | 22 (88.0) | 57 (85.1) |
  Periductal infiltrative | 3 (12.0) | 10 (14.9) |
 LN metastasis, n (%) | 21 (84.0) | 55 (82.1) |
 Extrahepatic metastasis, n (%) | 11 (44.0) | 38 (56.7) |
 CA 19–9, U/mL | 1684.7 ± 4881.2 | 3121.7 ± 9622.1 |
 CEA, ng/mL | 26.5 ± 53.9 | 190.3 ± 764.0 |